Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Net Income (2017 - 2025)

Selectis Health's Net Income history spans 14 years, with the latest figure at -$502660.0 for Q3 2025.

  • For Q3 2025, Net Income rose 69.41% year-over-year to -$502660.0; the TTM value through Sep 2025 reached -$2.6 million, up 67.52%, while the annual FY2024 figure was -$4.8 million, 57.1% up from the prior year.
  • Net Income for Q3 2025 was -$502660.0 at Selectis Health, up from -$676280.0 in the prior quarter.
  • Across five years, Net Income topped out at $987560.0 in Q2 2022 and bottomed at -$3.7 million in Q4 2023.
  • The 5-year median for Net Income is -$1.3 million (2024), against an average of -$1.3 million.
  • The largest annual shift saw Net Income tumbled 1451.62% in 2021 before it skyrocketed 252.37% in 2022.
  • A 5-year view of Net Income shows it stood at -$2.0 million in 2021, then dropped by 12.4% to -$2.2 million in 2022, then tumbled by 65.07% to -$3.7 million in 2023, then surged by 87.67% to -$452978.0 in 2024, then fell by 10.97% to -$502660.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Net Income are -$502660.0 (Q3 2025), -$676280.0 (Q2 2025), and -$964413.0 (Q1 2025).